Janney Montgomery Scott LLC Acquires 3,751 Shares of Healthequity Inc (NASDAQ:HQY)

Janney Montgomery Scott LLC lifted its holdings in shares of Healthequity Inc (NASDAQ:HQY) by 38.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,616 shares of the company’s stock after acquiring an additional 3,751 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Healthequity were worth $778,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. BlackRock Inc. raised its holdings in Healthequity by 13.1% in the second quarter. BlackRock Inc. now owns 7,268,685 shares of the company’s stock worth $475,373,000 after purchasing an additional 840,177 shares in the last quarter. Renaissance Technologies LLC raised its holdings in Healthequity by 76.8% in the second quarter. Renaissance Technologies LLC now owns 1,162,234 shares of the company’s stock worth $76,010,000 after purchasing an additional 504,700 shares in the last quarter. Nuveen Asset Management LLC bought a new position in Healthequity in the second quarter worth $30,550,000. D. E. Shaw & Co. Inc. raised its holdings in Healthequity by 1,745.8% in the second quarter. D. E. Shaw & Co. Inc. now owns 476,201 shares of the company’s stock worth $31,144,000 after purchasing an additional 450,402 shares in the last quarter. Finally, Copper Rock Capital Partners LLC bought a new position in Healthequity in the third quarter worth $15,195,000. Institutional investors own 85.23% of the company’s stock.

Shares of NASDAQ:HQY traded up $0.68 on Tuesday, hitting $61.41. 16,369 shares of the company traded hands, compared to its average volume of 545,411. Healthequity Inc has a 52 week low of $50.29 and a 52 week high of $96.81. The company has a quick ratio of 22.98, a current ratio of 22.98 and a debt-to-equity ratio of 0.04. The stock has a 50 day simple moving average of $56.82 and a 200-day simple moving average of $65.11. The company has a market cap of $4.36 billion, a PE ratio of 64.55, a PEG ratio of 3.34 and a beta of 1.50.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 3rd. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.10. Healthequity had a return on equity of 11.77% and a net margin of 28.13%. The firm had revenue of $86.60 million during the quarter, compared to the consensus estimate of $85.33 million. During the same period last year, the company earned $0.36 earnings per share. The company’s revenue was up 21.8% on a year-over-year basis. As a group, sell-side analysts anticipate that Healthequity Inc will post 0.93 earnings per share for the current year.

In other news, CFO Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $60.82, for a total transaction of $243,280.00. Following the completion of the transaction, the chief financial officer now directly owns 50,100 shares in the company, valued at $3,047,082. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold 12,000 shares of company stock valued at $717,320 over the last 90 days. Corporate insiders own 3.70% of the company’s stock.

A number of research firms have issued reports on HQY. SunTrust Banks decreased their price objective on Healthequity to $80.00 and set a “buy” rating for the company in a report on Monday, September 9th. Raymond James upgraded Healthequity from an “outperform” rating to a “strong-buy” rating and decreased their price objective for the stock from $90.00 to $80.00 in a report on Monday, September 9th. Goldman Sachs Group began coverage on Healthequity in a report on Monday, October 7th. They issued a “neutral” rating and a $56.00 price objective for the company. Wells Fargo & Co decreased their price objective on Healthequity from $80.00 to $76.00 and set an “outperformer” rating for the company in a report on Wednesday, September 4th. Finally, Barrington Research reiterated an “outperform” rating and issued a $75.00 price objective (down previously from $100.00) on shares of Healthequity in a report on Wednesday, September 4th. Three research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $77.00.

Healthequity Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Article: Understanding each part of a balance sheet

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit